🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/2013 | 41,66 | 41,77 | 41,47 | 41,51 | -0,37% | 0,71% | 13.280.885 |
| 29/01/2013 | 41,21 | 41,74 | 41,02 | 41,66 | +1,70% | 1,74% | 16.474.874 |
| 28/01/2013 | 41,36 | 41,51 | 40,96 | 40,96 | -1,22% | 1,32% | 12.418.800 |
| 25/01/2013 | 41,15 | 41,47 | 40,76 | 41,47 | +1,07% | 1,72% | 13.799.330 |
| 24/01/2013 | 40,98 | 41,23 | 40,96 | 41,03 | +0,42% | 0,65% | 13.096.122 |
| 23/01/2013 | 41,03 | 41,11 | 40,60 | 40,86 | -0,88% | 1,23% | 14.854.666 |
| 22/01/2013 | 40,81 | 41,24 | 40,66 | 41,22 | +0,51% | 1,43% | 12.819.765 |
| 18/01/2013 | 40,92 | 41,01 | 40,70 | 41,01 | +0,54% | 0,77% | 17.222.937 |
| 17/01/2013 | 40,85 | 40,89 | 40,59 | 40,79 | +0,49% | 0,72% | 16.255.109 |
| 16/01/2013 | 40,93 | 41,07 | 40,55 | 40,59 | -0,77% | 1,26% | 12.481.156 |
| 15/01/2013 | 41,39 | 41,55 | 40,85 | 40,91 | -1,08% | 1,68% | 12.446.677 |
| 14/01/2013 | 41,33 | 41,56 | 41,08 | 41,36 | +0,25% | 1,18% | 11.650.721 |
| 11/01/2013 | 40,75 | 41,35 | 40,75 | 41,25 | +1,05% | 1,45% | 12.722.825 |
| 10/01/2013 | 40,91 | 41,17 | 40,79 | 40,82 | +0,45% | 0,93% | 13.593.084 |
| 09/01/2013 | 40,45 | 40,70 | 40,27 | 40,64 | +0,97% | 1,06% | 10.556.609 |
| 08/01/2013 | 40,31 | 40,73 | 40,25 | 40,25 | +0,14% | 1,21% | 15.458.943 |
| 07/01/2013 | 40,11 | 40,26 | 39,93 | 40,19 | +0,36% | 0,81% | 12.055.773 |
| 04/01/2013 | 40,52 | 40,55 | 39,90 | 40,05 | -0,85% | 1,60% | 16.169.068 |
| 03/01/2013 | 39,97 | 40,49 | 39,23 | 40,39 | +2,39% | 3,15% | 24.673.483 |
| 02/01/2013 | 39,94 | 39,95 | 39,06 | 39,45 | +0,98% | 2,22% | 16.722.831 |
| 31/12/2012 | 38,44 | 39,09 | 38,19 | 39,06 | +0,74% | 2,36% | 15.004.635 |
| 28/12/2012 | 39,12 | 39,28 | 38,77 | 38,78 | -1,36% | 1,32% | 11.862.731 |
| 27/12/2012 | 39,32 | 39,51 | 38,93 | 39,31 | -0,34% | 1,48% | 11.948.877 |
| 26/12/2012 | 39,55 | 39,68 | 39,33 | 39,45 | -0,19% | 0,87% | 7.471.716 |
| 24/12/2012 | 39,53 | 39,84 | 39,42 | 39,52 | -0,24% | 1,06% | 6.793.870 |
| 21/12/2012 | 40,48 | 40,52 | 39,55 | 39,62 | -1,52% | 2,38% | 30.087.242 |
| 20/12/2012 | 40,51 | 40,82 | 40,08 | 40,23 | -3,44% | 1,84% | 35.263.104 |
| 19/12/2012 | 42,13 | 42,42 | 41,61 | 41,66 | -1,31% | 1,93% | 12.254.369 |
| 18/12/2012 | 41,59 | 42,37 | 41,37 | 42,21 | +1,40% | 2,39% | 14.756.888 |
| 17/12/2012 | 41,63 | 41,83 | 41,52 | 41,63 | +0,21% | 0,76% | 13.917.650 |